Drug Development Services Japan

At Covance, we’ve worked in Japan for more than 20 years to build operational excellence and serve as a resourceful specialist. Whether you are a Japanese company interested in bringing your drug to Western markets or a global company wanting to partner in Japan, you can count on our expertise. With fluency in both English and Japanese, and a strong understanding of the cultural nuances, our staff is equipped to serve as your insightful partner.  

  • Maximize development ROI with integrated local and global solutions 

  • Faster recruitment with access to investigators and patients in more than 100 countries worldwide

  • More than 99% of data packages delivered on time

Photo of Japanese drug development scientists working in a Covance lab.
Solutions in Japan

Gain access to the U.S. or European markets through our proven global network of solutions. Discover how we can help meet your goals.

Local Expertise

We understand the level of service and attention to detail expected for all interactions. As your partner, we are equipped to satisfy your needs and provide insights to move your project forward.

  • Diverse expertise: Benefit from the vast breadth and depth of knowledge from our scientific experts and managers to help meet your challenges. Our experts are fluent in both Japanese and English to help facilitate clear and streamlined communication.
  • Regulatory support: Get experienced consulting with your product development plan and regulatory submissions from our regulatory personnel who have years of product development experience and proactively stay abreast of the latest regulatory changes. Register your compound in the U.S., European and Rest-of-World with the support of our skilled regulatory staff who have extensive experience interacting with PMDA, FDA, EMA and other Health Authorities globally. 

The Japanese healthcare market is often characterized by its aging population and traditionally high use of medicines. Japan has number of other attributes to consider in the industry:

  • A strong presence: When compared country by country, the Japanese pharmaceutical sector is the second largest in the world with the U.S. as first and Germany as third.
  • Sophisticated knowledge: The Japanese clinical drug development market is considered very mature as compared to other emerging Asian Pacific countries.
  • Opportunities for generics: The generic drug sector is increasingly attractive to foreign manufacturers given that government initiatives are aimed at reducing healthcare spending and meeting the needs of a rapidly aging demographic. 

At Covance, we understand all of these factors that make Japan an attractive yet challenging market for partnerships, both locally and globally. We’re ready to work with you and explore what’s possible. 

+81 3-6837-9500

Office Address:


Harumi Triton Square Office Tower Y 8F
1-8-11 Harumi, Chuo-ku
Tokyo 104-6108 Japan


Covance Japan Co. Ltd
Tokyo Tatemono Umeda Bldg 13F
1-12-12 Umeda, Kita-ku
Osaka-shi, Osaka 530-0001